Hua-Xin Liao

USPTO Granted Patents = 40 (Patent Applications = 29)

CIPO Patents = 7 (Patent Applications = 16)

EPO Patents = 7 (Patent Applications = 26)

Average Co-Inventor Count = 4.8

ph-index = 4

Forward Citations = 142(Granted Patents)

Location History:

Chapel Hill, NC (US) (1999 - 2017)
Durham, NC (US) (2011 - 2024)

Company Filing History:

Beth Israel Deaconess Medical Center, Inc.

patents

8 out of 575

Los Alamos National Security, LLC

patents

4. 8 out of 634

The UAB Research Foundation (the University of Alabama at Birmingham)

patents

5. 4 out of 289

Triad National Security, LLC

patents

6. 3 out of 2,620

University of Pennsylvania

patents

7. 2 out of 15,502

University of California

patents

8. 2 out of 1,934

University System of Maryland

The United States of America, As Represented by the Secretary, Department of Health and Human Services

patents

11. 2 out of 5,309

Leland Stanford Junior University

patents

12. 1 out of 504

Albert Einstein College of Medicine

patents

13. 1 out of 1,274

The University of North Carolina at Chapel Hill

patents

14. 1 out of 512

Sloan-kettering Institute for Cancer Research

patents

15. 1 out of 1,210

Dana-farber-cancer Institute Inc.

patents

16. 1 out of 1,035

Children's Medical Center Corporation

patents

where one patent can have more than one assignee

Years Active: 1999-2025

Loading Chart...

Areas of Expertise:

Complement Factor H

HIV-1 Neutralizing Antibodies

Immunogens

Antibody Evolution

Liposome-Peptide Conjugates

Broadly Neutralizing Antibodies

Mosaic Clade M HIV-1

Nucleic Acids Encoding Immunogens

Human Immunodeficiency Virus

V3-Specific Antibodies

CD4 Binding Site Antibodies

Protective Antibodies

40 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12286471 - Inhibitors of complement factor H (2025-04-29),

2. 11944681 - HIV-1 neutralizing antibodies and uses thereof (2024-04-02),

3. 11897946 - Methods of inhibiting complement factor H (CFH) comprising administering an antibody that binds CFH (2024-02-13),

4. 11884704 - Compositions comprising HIV envelopes to induce CH235 lineage antibodies (2024-01-30),

5. 11136380 - Anti-complement factor H antibodies (2021-10-05),

6. 11077130 - Methods for reducing HIV-1 mother-to-child transmission by inducing V3-specific or CD4 binding site-specific antibodies (2021-08-03),

7. 11071783 - HIV-1 neutralizing antibodies and uses thereof (2021-07-27),

8. 10968255 - Compositions comprising HIV envelopes to induce CH235 lineage antibodies (2021-04-06),

9. 10946090 - Consensus/ancestral immunogens (2021-03-16),

10. 10865238 - Complement factor H antibodies (2020-12-15),

11. 10849970 - Antibody evolution immunogens (2020-12-01),

12. 10588960 - Liposome-peptide conjugate and method of using same to induce production of anti-HIV antibodies (2020-03-17),

13. 10561725 - Method of inducing the production of protective anti-HIV-1 antibodies (2020-02-18),

14. 10450368 - HIV-1 neutralizing antibodies and uses thereof (CD4bs antibodies) (2019-10-22),

15. 10344077 - HIV-1 neutralizing antibodies and uses thereof (V3 antibodies) (2019-07-09),

Title: The Innovative Journey of Hua-Xin Liao

Introduction: Hua-Xin Liao, a pioneering inventor based in Durham, NC, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: Hua-Xin Liao holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and forward-thinking approach to invention.

Career Highlights: With a background in engineering and a passion for problem-solving, Hua-Xin Liao has led successful projects that have revolutionized industries and improved the lives of many. His dedication to innovation is evident in the numerous awards and accolades he has received throughout his career.

Collaborations: Hua-Xin Liao has collaborated with leading research institutions, universities, and tech companies to further develop his inventions and bring them to market. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: In conclusion, Hua-Xin Liao's innovative spirit, coupled with his technical expertise and collaborative mindset, continues to drive forward progress in the world of technology. His contributions have left a lasting impact on the industry and inspire future generations of inventors to push the boundaries of what is possible.

This text is generated by artificial intelligence and may not be accurate.